local_hospital

Medical Center Sun I Zdrave Ltd.

Address
lock Available on a paid plan

Respiratory Tract Diseases Research

At Medical Center Sun I Zdrave Ltd. in Sofia, clinical trials in respiratory medicine focus on chronic lung conditions such as asthma, Chronic Obstructive Pulmonary Disease (COPD), and chronic bronchitis. The studies are designed to assess how well new or add-on treatments can improve disease control and reduce worsening symptoms.

  • Evaluating treatments for asthma and COPD
  • Studying chronic bronchitis as part of obstructive lung disease research
  • Testing whether new therapies can lower exacerbations and improve breathing outcomes

Overall, this area of research is centered on improving treatment effectiveness and long-term symptom management for people with persistent respiratory disease.

Nervous System Diseases Research

The site also supports studies in nervous system diseases, with a focus on insomnia disorder in children and adolescents. This research aims to better understand sleep problems and evaluate whether new therapies can safely improve sleep quality and duration.

  • Investigating insomnia disorder in pediatric and adolescent patients
  • Measuring changes in total sleep time and sleep improvement
  • Assessing the safety and effectiveness of a potential sleep treatment

These trials reflect a broader effort to improve diagnosis and treatment options for sleep-related conditions affecting younger patients.

Site Overview

assignment
4
connected trials
corporate_fare
2
sponsors
science
7
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
4
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
2
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 476 other sites in Bulgaria

description
Trial volume
4
Outperforms 54% of sites
public
Therapeutic diversity
2areas
Outperforms 47% of sites
groups
Sponsor diversity
2sponsors
Outperforms 38% of sites

Therapeutic Area Benchmark — Bulgaria

Select a therapeutic area to compare against other sites in Bulgaria.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Bulgaria

Market Share

Country: Bulgaria

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Medical Center Sun I Zdrave Ltd.

lock Showing 1 of 4 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Dose-Response Evaluation of Daridorexant in Pediatric Insomnia: A Randomized, Double-Blind, Placebo-Controlled Polysomnography StudyIdorsia Pharmaceuticals Ltd.Phase IINot RecruitingDec 2022Feb 2026

IMP list

lock Showing 1 of 7 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Tanimilast2Unknown2021-06-162021-06-17

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.